HAVCR2 and acute myeloid leukemia: The results showed that the AML patients in the Tim‐3high group had poor DFS and OS than those in the Tim‐3low group, further confirming that Tim‐3 is of great significance for predicting the prognosis of AML patients (Figure 6B, C).